How does ChatGPT work? And its creator? Are you ready to cooperate with the vaccine?

Published Date: 16 Feb 2023

Chatbots have shields to control misinformation, but it will continue to be a game.

Read Full News

Latest News

Highlights in Poststroke Care From ISC 2026

Highlights in poststroke care from ISC 2026 include benefits of asundexian, promise of an investigational revascularization device, postthrombectomy alteplase, and pediatric movement therapy.

Hallucinogens: High Risk or High Reward?

Dr Tyler Durns breaks down the real-world violence risk of psilocybin, LSD, and MDMA — and how clinicians should assess and counsel patients.

Hands-On Care for Healing We Are Not Machines

A retired cardiologist laments the move away from physical touch in patient-clinician encounters.

Colorectal Cancer Prevention Happens Beyond Colonoscopy

March is colorectal awareness month. Dr Alicia Muratore discusses why gastroenterologists should prioritize outreach.

What I Wish I Knew As A Family Medicine Resident

Medical school teaches the “hard” skills, but what about the rest? Drs Petty and Bhingradia discuss emotional intelligence, difficult conversations, and negotiating for the career you want.

Patient-Reported Gaps Between Care Goals in Advanced Cancer

Dr Maurie Markman discusses new data showing that many patients with advanced cancer perceive a mismatch between their comfort-focused goals and the care they receive.

Todays Updates

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.

Todays Updates

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.

Latest News

Highlights in poststroke care from ISC 2026 include benefits of asundexian, promise of an investigational revascularization device, postthrombectomy alteplase, and pediatric movement therapy.

Dr Tyler Durns breaks down the real-world violence risk of psilocybin, LSD, and MDMA — and how clinicians should assess and counsel patients.

A retired cardiologist laments the move away from physical touch in patient-clinician encounters.

March is colorectal awareness month. Dr Alicia Muratore discusses why gastroenterologists should prioritize outreach.

Medical school teaches the “hard” skills, but what about the rest? Drs Petty and Bhingradia discuss emotional intelligence, difficult conversations, and negotiating for the career you want.

Dr Maurie Markman discusses new data showing that many patients with advanced cancer perceive a mismatch between their comfort-focused goals and the care they receive.

News All Time

Precompetition Abstinence: Evidence Challenges Myth

Published findings suggest clinicians should avoid blanket abstinence and offer individualized, stigma-free guidance on sleep and recovery for competitive athletes.

Zongertinib Picks Up First-Line Metastatic NSCLC Indication

The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior systemic therapy.

Medium-Chain Triglycerides Can Improve Quality of Life in RA

Incorporating medium-chain triglycerides into the regular diet of patients with rheumatoid arthritis can improve their mental well-being and social functioning, a 16-week randomized trial shows.

How Nanotech Made an Old Leukemia Drug 22,000x Stronger

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Gambling Frequency Tied to Increased Harm Risk in UK Survey

A study of over 16,000 adults in England and Scotland finds a significant positive association between gambling frequency and the risk for gambling-related harm.

‘Nearly Every’ Child With Measles Suffers This Hidden Threat

Immune amnesia — measles’ little-known complication — can leave unvaccinated children at a higher risk for infections for years.

EMA Backs Single-Dose Pill for Sleeping Sickness

For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients lumbar puncture and inpatient care.

EMA Backs Continuous Infusion Levodopa for Parkinson’s

Designed for advanced Parkinson’s with poorly controlled motor fluctuations, the infusion delivers steadier levodopa exposure than pills via continuous subcutaneous dosing.

EMA Backs First Combined mRNA Vaccine for COVID-19 and Flu

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

Exercise May Up QoL When Taking Chemo for Breast Cancer

A new study examines how exercise modality and dose could affect quality of life outcomes in women undergoing chemotherapy for breast cancer.

Early Bleeding Alone Not Tied to Pregnancy Loss Risk

First-trimester bleeding is not linked to a risk for pregnancy loss, but bleeding with ultrasound dating that is more than 5 days behind the last menstrual period date is tied to a higher risk.

Does This ED Drug Harm the Retina?

The use of sildenafil is associated with an increased risk for serous retinal detachment in men with erectile dysfunction, a study finds.

Why All Mammograms Should Incorporate AI

Eric Topol details the benefits of incorporating artificial intelligence into mammogram screenings.

SNNOOP10 to Screen for Primary vs Secondary Headaches

Dr Nina Lum discusses the SNNOOP10 mnemonic for screening for primary vs secondary headaches.

Infographic: Foreign-Trained Docs Help With Shortage Here

Strong majorities of physicians in the US think doctors trained in other countries receive solid schooling and training and could help with shortages here.

Recommended News For You

Understudied mental health challenges among caregivers of cancer patients: A call for targeted support

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

Approved BTK Inhibitor Without Covalent Bond for CLL.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

Recommended Articles For You

Everything You Need to Know About RDW-CV: A Comprehensive Guide  

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms 

Improving TIVAP Use: Review of Standardization and Optimization Practices 

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

2.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

3.

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

4.

How Do Younger People Fare With Stool Tests for CRC Screening?

5.

AI catches one-third of interval breast cancers missed at screening

1.

Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More

2.

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition

3.

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs

4.

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies

5.

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

3.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

5.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot